PT88527A - Procede de synthese industrielle du perindopril et des principaux intermediaires de synthese - Google Patents

Procede de synthese industrielle du perindopril et des principaux intermediaires de synthese

Info

Publication number
PT88527A
PT88527A PT88527A PT8852788A PT88527A PT 88527 A PT88527 A PT 88527A PT 88527 A PT88527 A PT 88527A PT 8852788 A PT8852788 A PT 8852788A PT 88527 A PT88527 A PT 88527A
Authority
PT
Portugal
Prior art keywords
synthese
perindopril
intermediaires
procede
industrielle
Prior art date
Application number
PT88527A
Other languages
English (en)
Other versions
PT88527B (pt
Inventor
Michel Vincent
Jean Baliarda
Bernard Marchand
Georges Redmond
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9354991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT88527(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adir filed Critical Adir
Publication of PT88527A publication Critical patent/PT88527A/pt
Publication of PT88527B publication Critical patent/PT88527B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Casting Devices For Molds (AREA)
PT88527A 1987-09-17 1988-09-16 Processo para a sintese industrial do perindopril e de seus principais intermedios de sintese PT88527B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712896A FR2620709B1 (fr) 1987-09-17 1987-09-17 Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese

Publications (2)

Publication Number Publication Date
PT88527A true PT88527A (pt) 1988-10-01
PT88527B PT88527B (pt) 1993-03-31

Family

ID=9354991

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88527A PT88527B (pt) 1987-09-17 1988-09-16 Processo para a sintese industrial do perindopril e de seus principais intermedios de sintese

Country Status (15)

Country Link
US (1) US4914214A (pt)
EP (1) EP0308341B1 (pt)
JP (1) JPH01110696A (pt)
AT (1) ATE59047T1 (pt)
CA (1) CA1336348C (pt)
DE (1) DE3861275D1 (pt)
DK (1) DK171470B1 (pt)
ES (1) ES2019703B3 (pt)
FR (1) FR2620709B1 (pt)
GR (1) GR3001539T3 (pt)
IE (1) IE61453B1 (pt)
NZ (1) NZ226224A (pt)
OA (1) OA08915A (pt)
PT (1) PT88527B (pt)
ZA (1) ZA886932B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012044189A1 (en) 2010-09-29 2012-04-05 Instituto Superior Técnico A new hydrated crystalline form of perindopril erbumine, methods for its preparation and its use in pharmaceutical preparations

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620699B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
US5212319A (en) * 1990-02-26 1993-05-18 Eli Lilly And Company Intermediates to 4-amino-hexahydrobenz[cd]indoles and processes therefor
FR2807037B1 (fr) * 2000-03-31 2002-05-10 Adir NOUVEAU PROCEDE DE SYNTHESE DES ESTERS DE LA N-[(s)-1- CARBOXYBUTYL]-(S)-ALANINE ET APPLICATION A LA SYNTHESE DU PERINDOPRIL
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2807430B1 (fr) * 2000-04-11 2002-05-17 Adir Nouveau procede de synthese des esters de la n-[(s)-1- carboxybutyl]-(s)-alanine et application a la synthese du perindopril
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
AU2007203451B2 (en) * 2000-07-06 2010-09-02 Les Laboratoires Servier Pharmaceutical composition containing a crystalline form of perindopril tert-butylamine salt
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
ES2289060T3 (es) * 2002-01-30 2008-02-01 Les Laboratoires Servier Proceso para la preparacion de perindopril de alta pureza y de intermedios utiles en su sintesis.
JP2005519098A (ja) * 2002-03-01 2005-06-30 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 変形性関節症の治療方法
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
JPWO2004065368A1 (ja) * 2003-01-21 2006-05-18 大原薬品工業株式会社 トランドラプリル合成中間体の製造方法
SI1403275T1 (sl) * 2003-02-28 2006-02-28 Servier Lab Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
ES2250847T3 (es) * 2003-02-28 2006-04-16 Les Laboratoires Servier Nuevo procedimiento de sintesis del acido (2s,3as,7as)-perhidroindol-2-carboxilico y sus eteres y su aplicacion a la sintesis de perindropil.
ES2307923T3 (es) * 2003-02-28 2008-12-01 Les Laboratoires Servier S.A. Procedimiento de preparacion de perindopril y sales del mismo.
GB0305066D0 (en) * 2003-03-06 2003-04-09 Ibm System and method for publish/subscribe messaging
PT1348684E (pt) * 2003-04-09 2006-05-31 Servier Lab Novo processo de sintese do acido (2s)-indolina-2-carboxilico e aplicacao a sintese do perindopril
WO2004099138A2 (en) * 2003-05-12 2004-11-18 Cipla Limited Process for the preparation of perindopril
SI21507A (sl) * 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
AU2004249345B8 (en) 2003-06-24 2009-06-25 Les Laboratoires Servier Novel crystalline forms of perindopril erbumine
ES2286393T3 (es) * 2003-06-30 2007-12-01 Les Laboratoires Servier Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.
AU2003300689B2 (en) * 2003-10-21 2009-01-29 Les Laboratoires Servier Novel method for preparation of crystalline perindopril erbumine
US20050171165A1 (en) * 2003-11-12 2005-08-04 Bhirud Shekhar B. Process for the preparation of perindopril
DK1422236T3 (da) * 2003-11-19 2007-06-11 Servier Lab Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf
ES2282586T3 (es) * 2003-11-19 2007-10-16 Les Laboratoires Servier Procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.
EP1420030A3 (fr) * 2003-12-10 2004-05-26 Les Laboratoires Servier Procédé de synthèse de dérivés de l'acide (2S, 3aS, 7aS) - 1 - [(S)-alanyl]-octahydro-1H-indole-2-carboxylique et application à la synthèse du perindopril
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
PT1729739T (pt) * 2004-03-29 2016-12-01 Servier Lab Processo para a preparação de uma composição farmacêutica sólida
GB2413128A (en) * 2004-04-13 2005-10-19 Neopharma Ltd Process for the preparation of perindopril
US20050250706A1 (en) * 2004-05-07 2005-11-10 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
US20060178422A1 (en) * 2004-05-31 2006-08-10 Ashok Kumar Process for making (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl] amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
JP4547245B2 (ja) * 2004-12-16 2010-09-22 株式会社パーマケム・アジア ペリンドプリルエルブミンのi型結晶、及びその製造方法
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
EP1987828A1 (en) 2005-01-06 2008-11-05 IPCA Laboratories Limited salts of perindopril and their use in the therapy of hypertension
MY138209A (en) * 2005-03-11 2009-05-29 Servier Lab New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
US7728151B2 (en) * 2005-03-14 2010-06-01 Lupin Limited Process for the purification of perindopril
US7291745B2 (en) * 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2008545006A (ja) * 2005-07-05 2008-12-11 シプラ・リミテッド Ace阻害剤の合成方法
CA2615691C (en) * 2005-07-25 2015-11-10 Lek Pharmaceuticals D.D. Process for the preparation of crystalline perindopril
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
EP1792896A1 (en) * 2005-12-01 2007-06-06 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of perindopril and salts thereof
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
EA200600630A1 (ru) * 2006-04-20 2007-02-27 ИСМАГИЛОВ, Искандар Халиуллович ζ-ЗЕТА ФОРМА ПЕРИНДОПРИЛ ЭРБУМИНА
EP1864973A1 (en) * 2006-06-09 2007-12-12 Sochinaz SA Process for the preparation of perindopril and salts thereof
EP2137148A1 (en) * 2007-03-22 2009-12-30 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CN101514180B (zh) * 2008-02-20 2012-08-01 上海医药工业研究院 培哚普利叔丁铵盐的ⅰ晶型及其制备方法
CA2919564A1 (en) 2008-06-24 2009-12-30 Mylan Laboratories Limited Polymorphic form gamma of perindopril (l)-arginine and processes for the preparation thereof
GB0910692D0 (en) 2009-06-20 2009-08-05 Teva Pharma Compound
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
CN106631977A (zh) * 2016-11-11 2017-05-10 上海雅本化学有限公司 一种s‑吲哚啉‑2‑羧酸合成的优化方法
CN108752259A (zh) * 2018-07-04 2018-11-06 南京方生和医药科技有限公司 培哚普利消旋体及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
EP0088350B1 (en) * 1982-03-08 1985-02-20 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
DE3431541A1 (de) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012044189A1 (en) 2010-09-29 2012-04-05 Instituto Superior Técnico A new hydrated crystalline form of perindopril erbumine, methods for its preparation and its use in pharmaceutical preparations

Also Published As

Publication number Publication date
NZ226224A (en) 1990-09-26
ATE59047T1 (de) 1990-12-15
DK515188A (da) 1989-03-18
PT88527B (pt) 1993-03-31
EP0308341B1 (fr) 1990-12-12
EP0308341A1 (fr) 1989-03-22
IE882806L (en) 1989-03-17
FR2620709B1 (fr) 1990-09-07
DE3861275D1 (de) 1991-01-24
JPH01110696A (ja) 1989-04-27
AU608363B2 (en) 1991-03-28
DK171470B1 (da) 1996-11-11
CA1336348C (fr) 1995-07-18
GR3001539T3 (en) 1992-11-23
JPH0543717B2 (pt) 1993-07-02
FR2620709A1 (fr) 1989-03-24
US4914214A (en) 1990-04-03
ES2019703B3 (es) 1991-07-01
AU2236288A (en) 1989-03-23
IE61453B1 (en) 1994-11-02
OA08915A (fr) 1989-10-31
ZA886932B (en) 1989-05-30
DK515188D0 (da) 1988-09-15

Similar Documents

Publication Publication Date Title
PT88527A (pt) Procede de synthese industrielle du perindopril et des principaux intermediaires de synthese
Tesser et al. The methylsulfonylethyloxycarbonyl group, a new and versatile amino protective function
Moree et al. Peptides containing a sulfinamide or a sulfonamide moiety: New transition-state analogues
ES2060594T3 (es) Proceso para purificar proteinas recombinantes y uso de productos de las mismas.
HUP0001453A2 (hu) Eljárás N-alkilezett aszpartámszármazék előállítására és tisztítására
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
PT76267A (fr) Procede d'obtention de composes derives de l'acide 3-hydroxybu-tanoique et procede d'obtention de compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide
GB1359123A (en) Preparation of aspartyl amino-acid alkyl esters
ES2124782T3 (es) Produccion de proteinas.
DE69122867T2 (de) Verfahren zur herstellung von s-acylderivaten des glutathion, und damit hergestellte verbindungen
US4952493A (en) Peptide substrates for detecting virus-specified protease activity
Narita Isolation of acetylpeptide from the protein of cucumber virus 4
PT88528A (pt) Procede de synthese industrielle de l'acide perhydroindole carboxylique-2(2s,3as,7as) application a la synthese de carboxyalkyl dipeptides
Saltman et al. Co‐oligopeptides of aromatic amino acids and glycine with variable distance between the aromatic residues. VII. Enzymatic synthesis of N‐protected peptide amides
LU79069A1 (fr) Procede de preparation de nouveaux oligopeptides trifluoromethylees derives de la l-alanine
SCHEINER‐BOBIS et al. Demonstration of an Mg2+‐induced conformational change by photoaffinity labelling of the high‐affinity ATP‐binding site of (Na++ K+)‐ATPase with 8‐azido‐ATP
Tamaki Studies on peptide antibiotic" gratisin".
Abe et al. Synthesis of cyclo-diglycyl-L-lysyl-diglycyl-L-lysyl and hydrolysis by trypsin
KURAHASHI Identity of Gramicidin S, J1 and J2
EP0462792A3 (en) Process for obtaining cellular protein having anti-hiv activity
Cron et al. Selective N-acylation of kanamycin A
Beyerman et al. Solid‐Phase synthesis of carboxyl‐terminal N‐substituted derivatives of oxytocin
Escher et al. IMPROVED SYNTHESES OF SUBSTANCE P AND ANALOGUES ON A PHENOLIC RESIN SUPPORT
McGraw Synthesis and enzymolysis of sequence peptide polymers related to collagen
Kenner Recent progress in the chemistry of peptides

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920914

PC3A Transfer or assignment

Free format text: 20011105 LES LABORATOIRES SERVIER FR

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080916